TegoScience Inc. (KOSDAQ:191420)

TegoScience Statistics

Total Valuation

TegoScience has a market cap or net worth of KRW 144.12 billion. The enterprise value is 105.81 billion.

Market Cap	144.12B
Enterprise Value	105.81B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TegoScience has 8.01 million shares outstanding.

Current Share Class	8.01M
Shares Outstanding	8.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	42.45%
Owned by Institutions (%)	0.15%
Float	4.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.12
PB Ratio	2.46
P/TBV Ratio	2.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-56.00
EV / Sales	16.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-52.65

Financial Position

The company has a current ratio of 29.64, with a Debt / Equity ratio of 0.26.

Current Ratio	29.64
Quick Ratio	26.61
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-7.60
Interest Coverage	-11.06

Financial Efficiency

Return on equity (ROE) is -3.51% and return on invested capital (ROIC) is -2.94%.

Return on Equity (ROE)	-3.51%
Return on Assets (ROA)	-2.73%
Return on Invested Capital (ROIC)	-2.94%
Return on Capital Employed (ROCE)	-3.69%
Revenue Per Employee	155.15M
Profits Per Employee	-44.98M
Employee Count	42
Asset Turnover	0.10
Inventory Turnover	1.18

Taxes

Income Tax	-503.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.18% in the last 52 weeks. The beta is 1.12, so TegoScience's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	+12.18%
50-Day Moving Average	17,632.20
200-Day Moving Average	16,713.50
Relative Strength Index (RSI)	52.68
Average Volume (20 Days)	21,214

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TegoScience had revenue of KRW 6.52 billion and -1.89 billion in losses. Loss per share was -237.00.

Revenue	6.52B
Gross Profit	4.56B
Operating Income	-2.97B
Pretax Income	-2.42B
Net Income	-1.89B
EBITDA	-2.42B
EBIT	-2.97B
Loss Per Share	-237.00

Balance Sheet

The company has 53.51 billion in cash and 15.28 billion in debt, giving a net cash position of 38.23 billion or 4,775.35 per share.

Cash & Cash Equivalents	53.51B
Total Debt	15.28B
Net Cash	38.23B
Net Cash Per Share	4,775.35
Equity (Book Value)	58.47B
Book Value Per Share	7,312.34
Working Capital	60.37B

Cash Flow

In the last 12 months, operating cash flow was -1.93 billion and capital expenditures -75.69 million, giving a free cash flow of -2.01 billion.

Operating Cash Flow	-1.93B
Capital Expenditures	-75.69M
Free Cash Flow	-2.01B
FCF Per Share	-251.03

Margins

Gross margin is 69.97%, with operating and profit margins of -45.60% and -28.99%.

Gross Margin	69.97%
Operating Margin	-45.60%
Pretax Margin	-37.14%
Profit Margin	-28.99%
EBITDA Margin	-37.21%
EBIT Margin	-45.60%
FCF Margin	n/a

Dividends & Yields

TegoScience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.31%
FCF Yield	-1.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 11, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jul 11, 2018
Split Type	Forward
Split Ratio	2

Scores

TegoScience has an Altman Z-Score of 4.27 and a Piotroski F-Score of 2.

Altman Z-Score	4.27
Piotroski F-Score	2